Deana Mohr, CEO of MUVON, nominated as finalist for SEF.WomenAward 2026

MUVON ranked as a top 3 Biotech and overall 18th in 2024s TOP 100 Swiss Startups ranking

Exciting news! A captivating interview with our co-founders Jenny Prange and Deana Mohr following the prestigious “Female innovator award 2023”. Their insights and stories are sure to inspire. Check it out!

MUVON's co-founders Deana Mohr and Jenny Prange received the Female Innovator of the year Award at the 6th Female Innovation Forum . A jury consisting of 24 members selected MUVON's two co-founders from a long-list of 60 nominees in recognition of their efforts over the past years to bring MUVON's innovative regenerative therapy from the lab into the clinics in order to provide women suffering from stress urinary incontinence access to an affordable, low risk & potentially cu

We are extremely proud to announce that MUVON has entered the prestigious Top 100 Swiss Startups list as the highest ranked newcomer in 2023. Ranked at Number 19 overall, we also have the honor to have been selected as one of the top 3 Biotech Startups of Switzerland. Since 2011, Switzerland celebrates the most promising Swiss startups at the TOP 100 Award Night . The Swiss Startup Ranking, organized by Venturelab , features startups that are not older than five years and are

It is the third consecutive year for MUVON Therapeutics AG to make it into the leading race for the most innovative Swiss biotech start up by public voting. Thanks to all who believe in us and are constantly supporting our mission on the way towards bringing a bright future to our patients. If you have not voted yet, you can still do it! https://lnkd.in/eD4fvDZg

With our novel therapy platform for skeletal muscle regeneration, the MUVON team has won the prize of 10k as a runner up for the ZKB Pionierpreis 2023. The Pionierpreis or "pioneer award" is considered the leading innovation award for deep-tech start-ups in Switzerland and a significant achievement for young companies. The Pioneer Award honors projects at the transition from an innovative idea to marketability. At this point, start-ups are still usually a long way from maki

MUVON's team is very proud to be amongst the 12 finalists for the ZKB Pionierpreis in 2023! The recognition of the impact of our mission is highly appreciated and we are looking forward to the final pitching days in May. The Pionierpreis has been awarded by the ZKB and the TECHNOPARK® Zürich foundation for 20 years and is seen as a leading innovation award for Swiss startups. Link to the full list of nominees.

MUVON Therapeutics, a spin-off from the University of Zurich developing a platform technology for the regeneration of skeletal muscle tissue, is proud to announce that its CEO and co-founder Deana Mohr, PhD, has been listed on the Top 30 In Vivo’s '2022 Rising Leaders' . The list features 30 investors, entrepreneurs and innovators with biopharma and medtech businesses from all over the world who drive health initiatives forward with their talent, creativity and strong leaders

MUVON Therapeutics was selected as one of twelve finalists for 2021's IFAS Innovation Challenge and placed second in the final pitching round. With this MUVON has won an exhibition booth at the IFAS Expo taking place in October 2022 in Zurich. The IFAS Innovation Challenge was set up by Cosanum AG (a leading, Swiss healthcare logistics company) to foster innovation in the Swiss healthcare system. Read the full announcement on LinkedIn . Image Source: Cosanum AG

MUVON Therapeutics CEO Deana Mohr was selected as one of ten Venture Leaders in Medtech to represent the Swiss National Startup Team in the USA this October. The Venture Leaders Medtech roadshow will introduce Switzerland’s most innovative mobile startups to international investors and industry leaders at the global hub of life sciences in the Greater Boston Area. Venture Leaders Medtech 2021 is organized by Venturelab and supported by EPFL (École polytechnique fédérale d

MUVON is excited to have been selected as one of the top 10 startups in the Health and Nutrition vertical of the 2021 >>venture>> startup competition. »venture» is an initiative of the ETH Zurich, McKinsey & Company, Switzerland, Knecht Holding, the innovation promotion agency CTI and EPFL Lausanne. As the leading Swiss-wide competition for the best business idea and the best business plan, »venture» supports young entrepreneurs in founding a company.